Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911909 · ClinicalTrials.gov registry record · NA
Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02911909 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 7 participants.
The verdict
NCT02911909, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The aim of this study is to determine if there is a difference in post operative rehabilitation after anterior cruciate ligament (ACL) reconstruction surgery while using moderated blood flow therapy vs. standard physical therapy. All patients undergoing ACL reconstruction, between the ages of 18-30, that consent to taking part in the study, and meet eligibility criteria, will be included in the study. Patients will be followed for two years to determine any differences in muscle strength, thigh circumference, knee range of motion, pain, functional and activity levels, patient satisfaction, levels of Human growth hormone HGH), Insulin-like Growth Factor (IGF), and Creatine Kinase (CK), KT2000, and Lachman physical examination.
Interventions
- OTHER Standard rehabilitation
- DEVICE Delfi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2019-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911909
The ClinicalTrials.gov registry entry for NCT02911909 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard rehabilitation is the first listed.
NCT02911909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02911909 about?
NCT02911909 is a clinical study titled "Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction". The aim of this study is to determine if there is a difference in post operative rehabilitation after anterior cruciate ligament (ACL) reconstruction surgery while using moderated blood flow therapy vs. standard physical therapy. All patients undergoing ACL reconstruction, between the ages of 18-30,...
What is the current status of trial NCT02911909?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-10-01. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT02911909?
The interventions under investigation include: Standard rehabilitation (OTHER), Delfi (DEVICE).
Who is sponsoring clinical trial NCT02911909?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.